Hereditary angioedema (HAE) – epidemiology, genetics and pathophysiology
11 – 20 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Complement Components in Peripheral Blood from Adult Patients with IDH Wild-Type Glioblastoma
- Contribution to journal › Article
-
Mark
“C1-inhibitor levels and Venous Thromboembolism : Results from a Mendelian Randomization Study”: comment from Grover et al
- Contribution to journal › Letter
-
Mark
High prevalence of interstitial lung abnormalities in middle-aged never-smokers
- Contribution to journal › Article
-
Mark
Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model
- Contribution to journal › Article
-
Mark
Trends in Treatments With Disease-Specific and Interfering Drugs in Patients With Hereditary Angioedema in Sweden
- Contribution to journal › Article
-
Mark
"Hereditary angioedema is associated with an increased risk of venous thromboembolism" : reply
- Contribution to journal › Letter
-
Mark
Substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) reprograms mucosal adaptations to chronic airway injury
- Contribution to journal › Scientific review
-
Mark
Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus : a case report
- Contribution to journal › Article
- 2022
-
Mark
Comorbidities in hereditary angioedema—A population-based cohort study
- Contribution to journal › Article
-
Mark
The effect of the COVID-19 pandemic on severe asthma care in Europe: Will care change for good?
- Contribution to journal › Article
